EUVIMEDEUVIMED entdecken
Klinische Studie

Effectiveness of Atomoxetine Augmentation in Reducing Nonsuicidal Self-Injury Among Adolescents with Attention Problems: A Preliminary Study

Dohyeong Lee iD, Su A Kwon iD, Mee Ae Kim iD, Kukju Kweon iD

Journal of Child and Adolescent Psychopharmacology · 2025

DOI: 10.1177/10445463251369688 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2025. Verfasst von Dohyeong Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Seoul Puren Psychiatry Clinic, Jeju, Republic of Korea. Hauptthemen laut MEDLINE: Atomoxetine Hydrochloride, Attention Deficit Disorder with Hyperactivity, Self-Injurious Behavior, Adrenergic Uptake Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This article presents the protocol for an open-label clinical trial examining the effectiveness of atomoxetine augmentation in adolescents with nonsuicidal self-injury (NSSI) and attention problems and reports preliminary findings from the initial group of participants.

Methods

Adolescents ( n = 27) aged 13–18 years who met the criteria for NSSI according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and had either full or subclinical attention-deficit/hyperactivity disorder (ADHD) were recruited. All participants had not received ADHD medication for at least 4 weeks prior to enrollment. Psychiatric diagnoses were confirmed using the Kiddie Schedule for Affective Disorders and Schizophrenia. After 12 weeks of adjunctive atomoxetine treatment, NSSI severity (primary outcome) was measured using the Inventory of Statements About Self-Injury. Secondary outcomes included the Children’s Depression Rating Scale (CDRS), the Children’s Depression Inventory (CDI), the Screen for Child Anxiety Related Emotional Disorders (SCARED), and DuPaul’s ADHD Rating Scale (ARS). Additional assessments targeting factors related to NSSI included demographic characteristics, childhood adversity, personality functioning, continuous performance task, and functional near-infrared spectroscopy.

Results

Twenty-three participants (22 female, 1 male) completed the trial (mean final dose: 58.3 ± 13.7 mg), while four discontinued (two voluntarily, two due to adverse events). Significant improvements were observed in CDRS ( p < 0.001), CDI ( p = 0.031), and NSSI severity ( p = 0.007). In the ADHD group, significant improvements were observed in CDRS ( p = 0.017) and NSSI severity ( p = 0.034), with a trend toward improvement in CDI ( p = 0.058). The subclinical ADHD group showed significant improvement in CDRS ( p = 0.006), with a trend toward improvement in NSSI severity ( p = 0.083).

Conclusion

Atomoxetine augmentation may reduce NSSI severity in adolescents with attention problems, particularly in those with comorbid ADHD, warranting further investigation in larger controlled trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atomoxetine HydrochlorideAttention Deficit Disorder with HyperactivitySelf-Injurious BehaviorAdrenergic Uptake InhibitorsHumansAdolescentMaleFemaleTreatment OutcomePsychiatric Status Rating ScalesSeverity of Illness Index

Stichwörter der Autor:innen

adolescentatomoxetineattention-deficit/hyperactivity disorderself-injurious behaviortreatment outcome

Substanzen

Atomoxetine HydrochlorideAdrenergic Uptake Inhibitors

Autor:innen und Institutionen

  • Seoul Puren Psychiatry Clinic, Jeju, Republic of Korea.
  • Department of Psychiatry, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Institute of Brain Research, Chungnam National University, Daejeon, Republic of Korea.
  • Department of Psychiatry, Chungnam National University School of Medicine, Daejeon, Republic of Korea.

ORCID-Profile: Dohyeong Lee, Su A Kwon, Mee Ae Kim, Kukju Kweon

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, D., Kwon, S. A., Kim, M. A., & Kweon, K. (2025). Effectiveness of Atomoxetine Augmentation in Reducing Nonsuicidal Self-Injury Among Adolescents with Attention Problems: A Preliminary Study. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1177/10445463251369688

Vancouver

Lee D, Kwon SA, Kim MA, Kweon K. Effectiveness of Atomoxetine Augmentation in Reducing Nonsuicidal Self-Injury Among Adolescents with Attention Problems: A Preliminary Study. Journal of Child and Adolescent Psychopharmacology. 2025. doi:10.1177/10445463251369688

BibTeX
@article{Lee2025,
  author = {Lee, Dohyeong and Kwon, Su A and Kim, Mee Ae and Kweon, Kukju},
  title = {Effectiveness of Atomoxetine Augmentation in Reducing Nonsuicidal Self-Injury Among Adolescents with Attention Problems: A Preliminary Study},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2025},
  doi = {10.1177/10445463251369688}
}
Kostenlos starten →